Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-10-27 Purchase | 2023-10-31 06:16 am | Greenwich LifeSciences Inc. | GLSI | Thompson Jaye VP Clinical Reg Affairs | 500 | $8.57 | $4,285 | 260,348 (Direct) | View |
| 2023-09-26 Purchase | 2023-09-28 06:05 am | Greenwich LifeSciences Inc. | GLSI | Thompson Jaye VP Clinical Reg Affairs | 600 | $8.71 | $5,226 | 259,848 (Direct) | View |
| 2023-07-13 Purchase | 2023-07-17 06:15 am | Greenwich LifeSciences Inc. | GLSI | Thompson Jaye VP Clinical Reg Affairs | 250 | $9.49 | $2,373 | 259,248 (Direct) | View |
| 2023-04-28 Purchase | 2023-05-02 06:06 am | Greenwich LifeSciences Inc. | GLSI | Thompson Jaye VP Clinical Reg Affairs | 250 | $11.22 | $2,805 | 258,998 (Direct) | View |
| 2023-04-11 Purchase | 2023-04-12 06:05 am | Greenwich LifeSciences Inc. | GLSI | Thompson Jaye VP Clinical Reg Affairs | 1,000 | $11.87 | $11,870 | 258,745 (Direct) | View |
| 2023-03-15 Purchase | 2023-03-16 06:05 am | Greenwich LifeSciences Inc. | GLSI | Thompson Jaye VP Clinical Reg Affairs | 250 | $12.71 | $3,178 | 257,745 (Direct) | View |
| 2023-02-24 Purchase | 2023-02-28 06:03 am | Greenwich LifeSciences Inc. | GLSI | Thompson Jaye VP Clinical Reg Affairs | 250 | $15.39 | $3,849 | 257,495 (Direct) | View |
| 2023-02-03 Purchase | 2023-02-07 06:10 am | Greenwich LifeSciences Inc. | GLSI | Thompson Jaye VP Clinical Reg Affairs | 250 | $20.84 | $5,210 | 257,245 (Direct) | View |
| 2023-01-27 Purchase | 2023-01-30 06:15 am | Greenwich LifeSciences Inc. | GLSI | Thompson Jaye VP Clinical Reg Affairs | 250 | $19.2 | $4,800 | 256,995 (Direct) | View |
| 2023-01-13 Purchase | 2023-01-17 06:02 am | Greenwich LifeSciences Inc. | GLSI | Thompson Jaye VP Clinical Reg Affairs | 250 | $16.5 | $4,125 | 256,745 (Direct) | View |
| 2022-12-16 Purchase | 2022-12-20 06:05 am | Greenwich LifeSciences Inc. | GLSI | Thompson Jaye VP Clinical Reg Affairs | 250 | $12.94 | $3,235 | 256,495 (Direct) | View |
| 2022-12-02 Purchase | 2022-12-06 06:15 am | Greenwich LifeSciences Inc. | GLSI | Thompson Jaye VP Clinical Reg Affairs | 250 | $13.98 | $3,495 | 256,245 (Direct) | View |
| 2022-04-19 Purchase | 2022-04-20 06:02 am | Greenwich LifeSciences Inc. | GLSI | Thompson Jaye VP Clinical Reg Affairs | 500 | $16.74 | $8,370 | 255,995 (Direct) | View |
| 2022-01-31 Purchase | 2022-02-01 06:01 am | Greenwich LifeSciences Inc. | GLSI | Thompson Jaye VP Clinical Reg Affairs | 500 | $18.47 | $9,235 | 255,495 (Direct) | View |
| 2022-01-21 Purchase | 2022-01-24 06:08 am | Greenwich LifeSciences Inc. | GLSI | Thompson Jaye VP Clinical Reg Affairs | 500 | $16.33 | $8,165 | 254,995 (Direct) | View |
| 2022-01-18 Purchase | 2022-01-19 06:09 am | Greenwich LifeSciences Inc. | GLSI | Thompson Jaye VP Clinical Reg. Affairs | 500 | $18.87 | $9,435 | 254,495 (Direct) | View |
| 2022-01-13 Purchase | 2022-01-14 06:06 am | Greenwich LifeSciences Inc. | GLSI | Thompson Jaye VP Clinical Reg. Affairs | 1,000 | $19.99 | $19,990 | 253,995 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-06-22 Option Award | 2022-06-24 08:14 am | N/A 2032-06-22 | Greenwich LifeSciences Inc. | GLSI | Thompson Jaye VP Clinical Reg Affairs | 149,818 | $0 | 149,818 (Direct) | View |
Ownership | 2022-01-11 06:05 am | N/A N/A | Greenwich LifeSciences Inc. | GLSI | Thompson Jaye VP Clinical & Reg. Affairs | 0 | $0 | 252,995 (Direct) | View |
Ownership(A) | 2020-09-30 9:02 pm | N/A N/A | Greenwich LifeSciences Inc. | GLSI | Thompson Jaye VP Clinical & Reg Affairs | 0 | $0 | 252,810 (Direct) | View |
Ownership | 2020-09-24 6:49 pm | N/A N/A | Greenwich LifeSciences Inc. | GLSI | Thompson Jaye VPC AND REGULATORY AFFAIRS | 0 | $0 | 140,450 (Direct) | View |